Issues guidance following a transformative year with the Company adding two new business lines, significantly strengthening ...

UNIONDALE, NY / ACCESS Newswire / March 31, 2025 / Marquis Who's Who honors Lakshmi Prasad Bhatta for his outstanding ...

Fourth Quarter 2024 vs. Fourth Quarter 2023 Revenue of $21.8 million compared to $23.5 million;Gross profit of $4.3 million compared to $4.1 ...

Transformational 2024: successfully advanced from preclinical to clinical stage companyStrengthened leadership team to drive growth and advance ...

For the three months ended December 31, 2024, net income increased by 9.9% to $9,164,362 as compared to $8,335,525 for the same period in 2023. Net income for the year ended December 31, 2024 ...

To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

Quarterly Adjusted EBITDA of $1.9 Million in Q4, a $4.9 Million Improvement YoY Annual Adjusted EBITDA of $(0.2) Million in 2024, a $12.8 Million ...

Grew Total Revenue 8% Year-over-Year to $45 Million in the Fourth Quarter 2024 - - Assets Under Management (“AuM”) Increased 13% Year-over-Year ...

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple ...

Revenue reached $74.67M, exceeding guidance and demonstrating continued strong sales growth and execution ---- Net Income excluding ...

Strengthened Cash Position Through Strategic Stock Sales and Debt FinancingFocused Growth Strategy Enhances Global Footprint and Distribution ...

Markets in Asia and Europe fell Monday ahead of US tariffs taking effect this week. Automakers also skidded lower, with ...